5,0
12 mar 2023
Dipendente attuale
Southampton, Inghilterra
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Innovators and industry leaders. Lots to learn
Svantaggi
Cash crisis is making future planning difficult
Vantaggi
Innovators and industry leaders. Lots to learn
Svantaggi
Cash crisis is making future planning difficult
Vantaggi
The small number of core people who cared and wanted to help and support end-users in challenging times.
Svantaggi
Higher management (now departed CCO for example) had little post-Covid actions/plans. Proposals of alternative areas to grow into (from sales teams on numerous occasions) were not recognised until it was very evident that covid testing demands were on the downturn. It’s unfortunate that there was lack of future planning based on utilising instrument install base to leverage the promate solution/technology within public and private sectors. The portfolio of RUO assays was strong but needed updated. If they were maintained it would have given a strong start to post covid markets prior to gaining CE-IVD/IVDR There was a toxic working environment within and between some commercial divisions. The lack of a proper e-commerce platform is telling of the position of where Novacyt currently is.
Vantaggi
Friendly lab staff in all departments
Svantaggi
Unfriendly and poor management in all departments